Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment.
Murine monoclonal antibody V5B2 which specifically recognizes the pathogenic form of the prion protein represents a potentially valuable tool in diagnostics or therapy of prion diseases. As murine antibodies elicit immune response in human, only modified forms can be used for therapeutic application...
Guardado en:
Autores principales: | Nives Skrlj, Tanja Vranac, Mara Popović, Vladka Curin Šerbec, Marko Dolinar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be19b155bb884f1797c78285b89242a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of Single-Chain Fv Fragments of Neutralizing Antibodies to Rabies Virus Glycoprotein
por: Kohei Yumoto, et al.
Publicado: (2021) -
Calcium binding promotes prion protein fragment 90-231 conformational change toward a membrane destabilizing and cytotoxic structure.
por: Sacha Sorrentino, et al.
Publicado: (2012) -
Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
por: David R Taylor, et al.
Publicado: (2009) -
Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by Lyophilization
por: Kai-Thomas Schneider, et al.
Publicado: (2021) -
Isolation and characterisation of a recombinant antibody fragment that binds NCAM1-expressing intervertebral disc cells.
por: Claire Cunningham, et al.
Publicado: (2013)